HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation Scanning of D1705 and D1709 in the RNAse IIIb Domain of MicroRNA Processing Enzyme Dicer in Cutaneous Melanoma.

Abstract
Since the discovery of microRNAs (miRNAs) there have been performed several studies showing perturbations in the expression of miRNAs and the miRNA expression machinery in cutaneous melanoma. Dicer, a pivotal cytosolic enzyme of miRNA maturation has shown to be affected by both somatic and germline mutations in a variety of cancers. Recent studies have shown that recurrent somatic mutations of Dicer frequently affect the metal-ion-binding sites D1709 and D1705 of its RNase IIIb domain, therefore called hot spot mutations. The present study investigates metal-ion-binding sites D1709 and D1705 of the Dicer RNase IIIb domain in cutaneous melanomas and melanoma metastasis by Sanger sequencing. All investigated samples showed wildtype sequence and no single mutation was detected. The miRNA processing enzyme Dicer of melanoma and melanoma metastasis does not appear to be affected by mutation in the metal-ion-binding sites D1709 and D1705 of its RNase IIIb domain.
AuthorsMichael Sand, Falk G Bechara, Marina Skrygan, Daniel Sand, Thilo Gambichler, Michael Bromba, Eggert Stockfleth, Schapoor Hessam
JournalPathology oncology research : POR (Pathol Oncol Res) Vol. 22 Issue 3 Pg. 639-41 (Jul 2016) ISSN: 1532-2807 [Electronic] Switzerland
PMID26683837 (Publication Type: Journal Article)
Chemical References
  • Ions
  • MicroRNAs
  • Ribonuclease III
Topics
  • Binding Sites (genetics)
  • Germ-Line Mutation (genetics)
  • Humans
  • Ions (metabolism)
  • Melanoma (genetics, metabolism)
  • MicroRNAs (genetics)
  • Neoplasm Metastasis (genetics)
  • Ribonuclease III (genetics)
  • Skin Neoplasms (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: